Best Life Sciences Companies in Sao Paulo, Brazil
The 41 best Life Sciences companies in Sao Paulo, Brazil in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Recepta Biopharma.
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Sao Paulo
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Recepta Biopharma Humanized monoclonal antibodies & peptides for cancer treatments | $3M | 169 mo ago | Series A | Jose Fernando Perez CEO | 2006 | BootstrapApache HTTP Serverlit-html+7 | — |
| 2 | Open Health AI-powered platform to analyse laboratory results | $3M | 11 mo ago | Seed | Gerrit Glass Co-Founder | 2022 | — | — |
| 3 | Gen-t Provider of gene bio-bank services to accelerate precision medicines | $2M | 34 mo ago | Seed | Lygia Pereira CEO | 2021 | WordPressMySQLPHP+32 | — |
| 4 | Ages Bioactive Developer of nutritional products for the prevention and modulation of chronic diseases | $554K | 49 mo ago | Seed | Alejandro Espinola Bustamante Co-Founder & Coo At Ages Bioactive Compounds | 2019 | WordPressMySQLPHP+24 | — |
| 5 | LizarBio Therapeutics Developer of cell therapies for heart and neurological problems | $250K | 50 mo ago | Seed | Marcos Valadares CEO | 2013 | — | — |
| 6 | Fix it Provider of prostheses to improve arm mobility in individuals | $95K | 46 mo ago | Seed | Hebert Costa Co-Founder & CPO | 2015 | WordPressMySQLPHP+29 | — |
| 7 | Magnamed Respiratory care, ICU or Transportation devices, and Emergency Line solutions | — | 218 mo ago | Seed | Wataru Ueda Founder & CEO | 2005 | WixSentryBootstrap+18 | 1 job opening |
| 8 | Pelenova Developer of tissue regenerative medicine | — | 279 mo ago | Funding Raised | Joaquim Coutinho Co-Founder | 1993 | — | — |
Top 7 Life Sciences companies in Sao Paulo
#1
Seed · Sao Paulo, State of Sao Paulo · founded 2022$3Mraised▾
AI-powered platform to analyse laboratory results. It offer software for laboratories, nutritionists, and doctors that integrates and analyses all different types of laboratory exams and structures the data into a harmonized standard.
- Sep 2025Seed$3M
#2
Seed · Sao Paulo, State of Sao Paulo · founded 2021$1.9Mraised▾
Provider of gene bio-bank services to accelerate precision medicines. It offers a platform for genetic biobank for genomic researcha to accelerate precision medicine and the development of medicines.
- Oct 2023Seed—
- Sep 2022Seed$1.9M
#3
Series A · Sao Paulo, Sao Paulo · founded 2006$3.4Mraised▾
ReceptaBio is developing monoclonal antibodies & peptides for cancer treatments. The company has a portfolio of monoclonal antibodies which are in clinical stages. The lead molecule, RebmAb100 is a humanized monoclonal antibody which targets Y antigen of the Lewis blood group (LeY). The company has conducted Phase II clinical trials for this molecule in Brazil in patients with ovarian and breast tumors. Other antibodies are RebmAb700 ( blocked PD-1) & RebmAb600 (blocks the antigen 4 associated with the cytotoxic T lymphocyte,CTLA-4), RebmAb200 (targets NaPi2b). The peptide portfolio includes Rb9 and Rb10, generated from the complementarity determining regions of humanized monoclonal antibodies.
- Jul 2012Series A$3.4M
#4
Seed · Sao Paulo, State of Sao Paulo · founded 2019 · 45 employees$553.8Kraised▾
Developer of nutritional products for the prevention and modulation of chronic diseases. The company focuses on the development of bioactive natural extracts that prevent and delay the aging process. The company's first product is a Phyto complex natural extract that acts on the musculoskeletal system to prevent and modulate major health problems such as osteopenia and osteoporosis, arthritis and arthrosis, myalgia, sarcopenia, and bone fragility, among others.
- Jul 2022Seed$553.8K
#5
Seed · Sao Paulo, State of Sao Paulo · founded 2013 · 7 employees$250Kraised▾
Developer of cell therapies for heart and neurological problems. It offers cardiac-cell-based therapeutics for Heart Failure and astrocytes-based therapeutics for Rett Syndrome.
- Jul 2022Seed$250K
#6
Seed · Sao Paulo, State of Sao Paulo · founded 2015 · 20 employees$95.1Kraised▾
Provider of prostheses to improve arm mobility in individuals. The platform is offering a 3D splint which is prepared by collecting your arm measurements. The orthosis is prepared using 3D printing technology. The orthosis made are eco-friendly.
- Nov 2022Seed$95.1K
#7
Seed · Sao Paulo, Brazil · founded 2005 · 132 employees—raised▾
Magnamed develops respiratory care, ICU or Transportation devices, and Emergency Line solutions. Products developed by the company include neonatal intensive care unit, ventilator (neonatal, pediatric and adult patients), lung ventilator, gas flow analyzer, and veterinary ventilator.
- 2008Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Brazil
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,470 Brazil-affiliated papers.
- Universidade de São Paulo120
- Universidade Estadual de Campinas113
- Universidade Estadual Paulista85
- Ministry of Education70
- Brazilian Agricultural Research Corporation64
- Gene9
- Genome7
- Metabolomics7
- Production (economics)6
- Livestock5
- Context (archaeology)2→47
- Fermentation2→36
- Antimicrobial3→34
- Bacteria1→17
- Biomass (ecology)1→17
- Biofuel1→5
- Fermentation1→5
- In vitro1→4
Where biotechnology is researched across Brazil
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.